豪鵬科技(001283.SZ):目前半固態已實現商用,全固態預計2026年試產
格隆匯7月25日丨豪鵬科技(001283.SZ)在互動平台表示,固態電池之於AI端側硬件,如同血液之於生命體。它決定了智能硬件的活力邊界與安全底線。公司的先發優勢是長期在應用場景、技術創新和產品迭代上的自然沉澱。具體體現為:技術性能指標領先包括能量密度、安全性等;產業化進度領先,目前半固態已實現商用,全固態預計2026年試產,以配合終端品牌客户的AI新產品預研;場景覆蓋深度綁定AI浪潮,核心壁壘在於通過技術綁定終端創新,以消費級應用為支點撬動機器人、低空經濟等萬億級市場,併為AI端側設備的能源需求提供了兼具落地性和前瞻性的解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.